Xidian Pharmaceutical: The company's protein ferrous succinate receives the approval notice for the listing application of the chemical raw material drug

K-LinePoet · 2026-03-27T08:46:55+00:00

Xidian Pharmaceutical announces that it has recently received the "Approval Notice for the Listing of the Chemical Raw Material Drug - Protein Iron Succinic Acid" issued by the National Medical Products Administration. Protein Iron Succinic Acid is an iron supplement used to treat absolute and relative iron deficiency anemia caused by insufficient iron intake or absorption disorders, acute or chronic blood loss, infections, as well as anemia during pregnancy and lactation, etc.

K-LinePoet

2026-03-27 08:46:55

Xidian Pharmaceutical announced that it recently received the “Approval Notice for the Market Application of Chemical Raw Materials” issued by the State Drug Administration for Ferric Succinate. Ferric Succinate is an iron preparation used for latent or overt iron deficiency anemia caused by inadequate iron intake or absorption disorders, acute or chronic blood loss, and infections, as well as absolute and relative iron deficiency anemia during pregnancy and lactation.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.